MedPath

Poitiers University Hospital

Poitiers University Hospital logo
🇫🇷France
Ownership
Private
Established
1961-01-01
Employees
5K
Market Cap
-
Website
https://www.chu-poitiers.fr

Glivec in Pediatric Chronic Myeloid Leukemia (CML)

Phase 4
Completed
Conditions
Chronic Myeloid Leukemia
Interventions
First Posted Date
2009-02-18
Last Posted Date
2016-10-11
Lead Sponsor
Poitiers University Hospital
Target Recruit Count
44
Registration Number
NCT00845221
Locations
🇫🇷

Hôpital La Timone - CHU de Marseille, Marseille, France

🇫🇷

CHU Amiens, Amiens, France

🇫🇷

Hôpital de Brabois - CHU de Nancy, Vendoeuvre les Nancy, France

Pharmacokinetics of Lenalidomide (Revlimid®) in Patients With Multiple Myeloma and Impaired Renal Function

Phase 2
Completed
Conditions
Multiple Myeloma
Impaired Renal Function
Interventions
First Posted Date
2008-10-24
Last Posted Date
2016-10-11
Lead Sponsor
Poitiers University Hospital
Target Recruit Count
39
Registration Number
NCT00779922
Locations
🇫🇷

Poitiers University Hospital, Poitiers, France

Maintenance Neoral Monotherapy Compared to Bitherapy in Renal Transplantation

Phase 3
Completed
Conditions
Kidney Transplantation
First Posted Date
2007-04-18
Last Posted Date
2007-04-18
Lead Sponsor
Poitiers University Hospital
Target Recruit Count
207
Registration Number
NCT00461825
Locations
🇫🇷

Reims University Hospital, Reims, France

🇫🇷

Dupuytren University Hospital, Limoges, France

🇫🇷

Rouen University Hospital, Rouen, France

and more 2 locations

Short or Long Schemes of Antibiotic Prophylaxis for Prostate Biopsy

Phase 3
Terminated
Conditions
Men Who Must Undergo a Prostate Biopsy Related to Prostate Cancer Suspicion.
First Posted Date
2006-02-22
Last Posted Date
2009-01-27
Lead Sponsor
Poitiers University Hospital
Target Recruit Count
300
Registration Number
NCT00294749
Locations
🇫🇷

Poitiers Hospital University, Poitiers, France

Chlorhexidine vs Povidone Iodine in Alcoholic Solutions for Prevention of Central Venous Catheter Infection

Phase 4
Completed
Conditions
ICU Patients Requiring a Central Venous Access
First Posted Date
2005-11-29
Last Posted Date
2009-01-27
Lead Sponsor
Poitiers University Hospital
Target Recruit Count
520
Registration Number
NCT00259350
Locations
🇫🇷

University hospital, Poitiers, Vienne, France

A Study on the Efficacy of 10 mg Oral Mifepristone for the Treatment of Symptomatic Uterine Leiomyomas

Phase 2
Terminated
Conditions
Leiomyoma
First Posted Date
2005-09-22
Last Posted Date
2016-04-06
Lead Sponsor
Poitiers University Hospital
Target Recruit Count
20
Registration Number
NCT00219778
Locations
🇫🇷

Poitiers University Hospital, Poitiers, France

Safety and Efficacy of Imatinib in Chronic Myelogenous Patients in Relapse After Stem Cell Transplantation

Phase 2
Completed
Conditions
Chronic Myeloid Leukemia
First Posted Date
2005-09-22
Last Posted Date
2012-08-29
Lead Sponsor
Poitiers University Hospital
Target Recruit Count
30
Registration Number
NCT00219726
Locations
🇫🇷

University Hospital, Poitiers, France

STI571 ProspectIve RandomIzed Trial: SPIRIT

First Posted Date
2005-09-22
Last Posted Date
2020-04-13
Lead Sponsor
Poitiers University Hospital
Target Recruit Count
789
Registration Number
NCT00219739
Locations
🇫🇷

University Hospital, Poitiers, France

Safety and Efficacy of Imatinib in Chronic Myelogenous Patients Older Than 70 Years

Phase 2
Completed
Conditions
Chronic Myeloid Leukemia
First Posted Date
2005-09-22
Last Posted Date
2005-12-22
Lead Sponsor
Poitiers University Hospital
Target Recruit Count
30
Registration Number
NCT00219752
Locations
🇫🇷

University Hospital, Poitiers, France

Safety and Efficacy of Imatinib in Combination With High Dose Chemotherapy for Acute Phase Chronic Myelogenous Patients

Phase 1
Terminated
Conditions
Chronic Myeloid Leukemia
First Posted Date
2005-09-22
Last Posted Date
2005-11-28
Lead Sponsor
Poitiers University Hospital
Target Recruit Count
30
Registration Number
NCT00219765
Locations
🇫🇷

University Hospital, Poitiers, France

© Copyright 2025. All Rights Reserved by MedPath